What is the typical cost of a cancer follow-up in public healthcare?

Question

Accepted Answer

The typical cost of a cancer follow-up in Malaysia's public healthcare system is as low as RM5.

A cancer follow-up appointment within Malaysia's public healthcare system can be very affordable, with costs starting as low as RM5. While the medication itself, such as Tamoxifen, may cost close to RM200 per month, this expense is fully covered by the public healthcare system, making essential treatments accessible to patients.
Minimal Out-of-Pocket Expenses for Patients

The financial burden on patients for routine cancer follow-ups is significantly low. The admission fee, which covers the consultation, is set at RM5. This minimal charge underscores the government's commitment to providing affordable healthcare, ensuring that financial constraints do not hinder patients from attending necessary medical appointments.
Medication Costs Covered by Public Healthcare

For patients requiring specific medications like Tamoxifen, which is crucial for hormone-sensitive breast cancers, the monthly cost of approximately RM200 is borne by the public healthcare system. This coverage is a critical support mechanism, alleviating the financial strain associated with long-term treatment regimens that can extend for 5 to 10 years.
Time Commitment and Process Efficiency

Despite the low financial cost, a cancer follow-up in the public system can be time-consuming, often taking up to half a day. The process typically involves multiple stages, including arriving early, surrendering appointment books, waiting for numbers, queuing for payment, seeing the doctor, and finally, obtaining the next appointment date and collecting medication from the pharmacy. This multi-step procedure can be challenging, particularly for elderly patients who may require assistance.

Reading history

Hide →

This history is cleared when the page is closed.

What is the typical cost of a cancer follow-up in public healthcare?

Loading

Was this article helpful?

Helpful

Not helpful

Report an issue

1

0

0

Share with friends